We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

117 hedge funds and large institutions have $349M invested in Aldeyra Therapeutics in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 45 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

773% more call options, than puts

Call options by funds: $19.1M | Put options by funds: $2.18M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

9.9% less ownership

Funds ownership: 78.59% → 68.69% (-9.9%)

14% less funds holding

Funds holding: 136 → 117 (-19)

32% less capital invested

Capital invested by funds: $511M → $349M (-$162M)

33% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 45

53% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 34

Holders
117
Holders Change
-19
Holders Change %
-13.97%
% of All Funds
2.05%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
30
Reduced
45
Closed
34
Calls
$19.1M
Puts
$2.18M
Net Calls
+$16.9M
Net Calls Change
+$14.4M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$3.62M
2
HP
HealthInvest Partners
Sweden
+$2.85M
3
State Street
State Street
Massachusetts
+$2.7M
4
EAM
Eagle Asset Management
Florida
+$2.39M
5
CM
Caption Management
Oklahoma
+$1.63M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$16.4M
2
TLP
Tri Locum Partners
New York
-$9.27M
3
Goldman Sachs
Goldman Sachs
New York
-$8.13M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$5.22M
5
AG
Artal Group
Luxembourg
-$4.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
PGAM
101
Princeton Global Asset Management
New Jersey
$44K – – –
HWM
102
HighMark Wealth Management
Minnesota
$40K +$1.81K +197 +5%
Royal Bank of Canada
103
Royal Bank of Canada
Ontario, Canada
$40K +$6.81K +742 +19%
AIP
104
Ameritas Investment Partners
Nebraska
$33K – – –
Bank Julius Baer & Co
105
Bank Julius Baer & Co
Switzerland
$31K -$275 -30 -0.8%
KFS
106
Kelly Financial Services
Massachusetts
$22K -$238K -25,897 -91%
ACM
107
ACT Capital Management
Pennsylvania
$13K – – –
SOW
108
State of Wyoming
Wyoming
$9K +$5.92K +645 +149%
Osaic Holdings
109
Osaic Holdings
Arizona
$6K – – –
TC
110
Truvestments Capital
Florida
$4K – – –
PA
111
PSI Advisors
Florida
$4K +$4.59K +500 New
NFG
112
Next Financial Group
Texas
$3K – – –
PNC Financial Services Group
113
PNC Financial Services Group
Pennsylvania
$2K +$1.81K +197 +386%
EBA
114
Eagle Bay Advisors
New York
$2K +$2.2K +240 New
EWM
115
Edge Wealth Management
New York
$1K – – –
APM
116
Avidity Partners Management
Texas
– -$16.4M -1,450,000 Closed
TLP
117
Tri Locum Partners
New York
– -$9.27M -818,025 Closed
AG
118
Artal Group
Luxembourg
– -$4.89M -431,894 Closed
EI
119
EAM Investors
California
– -$3.72M -328,539 Closed
SCM
120
Segantii Capital Management
Hong Kong
– -$2.27M -200,000 Closed
SCM
121
Silverarc Capital Management
Massachusetts
– -$2.18K -192,345 Closed
Walleye Capital
122
Walleye Capital
New York
– -$2.04K -179,810 Closed
SFM
123
Sphera Funds Management
Israel
– -$1.7M -150,000 Closed
MIM
124
Monashee Investment Management
Massachusetts
– -$1.66M -146,584 Closed
First Trust Advisors
125
First Trust Advisors
Illinois
– -$1.66M -146,320 Closed
2 3 4
5
6

ALDX Hedge Fund Activity: Q3 2021 in Review

117 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q3 2021, worth a combined $349M — down 32% from $511M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of ALDX and 16 opened new positions — a net loss of 18 holders — while 45 trimmed existing stakes and 30 added.

The largest buyer was Woodline Partners, adding an estimated $3.62M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $16.4M sold.

  • 117 institutional investors held Aldeyra Therapeutics (ALDX) as of Q3 2021, down from 136 in Q2 2021.
  • Funds reported $349M of Aldeyra Therapeutics stock for Q3 2021, down 32% quarter-over-quarter.
  • 16 funds opened new Aldeyra Therapeutics positions in Q3 2021 and 34 closed out, a net change of -18 holders.
  • The largest Aldeyra Therapeutics buyer in Q3 2021 was Woodline Partners, an estimated $3.62M added.
  • The largest Aldeyra Therapeutics seller in Q3 2021 was Avidity Partners Management, an estimated $16.4M sold.

Based on aggregated 13F filings for Q3 2021.